Thermo fisher scientific launches CE-IVD-marked next-Generation TaqPath COVID-19 2.0 test
Updated version of highly sensitive and accurate COVID-19 PCR kit accounts for known and future viral mutations
Updated version of highly sensitive and accurate COVID-19 PCR kit accounts for known and future viral mutations
Agreement to leverage manufacturing capacity to continue to drive global supply of vaccines
The collaboration aims to secure manufacturing and testing capacity in the next phase of the pandemic
The addition of COVID-19 antibody tests to the portfolio aims to further support the pandemic response on multiple fronts
Program will leverage Ion Torrent Genexus System and Oncomine Precision Assay to advance precision medicine for lung cancer in Asia
The TaqPath test is authorized for use with the Everlywell COVID-19 Test Home Collection Kit, which enables individuals to self-collect nasal swab specimens
The agreement allows First Genetics to bring its F-Genetics NGS system and in vitro diagnostic assays for reproductive health testing to Russian labs
Co-marketing agreement between Thermo Fisher Scientific and TransMIT allows for high spatial and high mass resolution MSI platform to study complex biological tissues
The Ion Torrent Genexus Dx Integrated Sequencer enables rapid NGS for diagnostic applications and clinical research
The new Thermo Scientific Vanquish Method Development HPLC and UHPLC system delivers robust and validated methods in less time with higher confidence
Gibco™ CTS Cellmation™ Software digitally connects instruments from across Thermo Fisher’s cell therapy portfolio to streamline and automate manufacturing
Genotype data from the kit will also be used to assist epidemiological and genetic surveillance studies to track the ongoing evolution of the virus
Thermo Scientific TSX and TSG Series meet stringent requirements for ensuring the safe storage and efficacy of temperature-sensitive vaccines, including those for COVID-19
Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing
Subsidized technology available as global bodies call for sequencing to confirm COVID-19 mutations